Companies › AURA

AURA BIOSCIENCES INC (AURA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001501796 · EDGAR filings · Updated 2026-07-27

AURA BIOSCIENCES INC (AURA) has reported institutional ownership of 79.3%, with 126 institutional managers holding positions valued at $340.3M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-08 — Insider transaction reported (Form 4)
• 2026-07-08 — Initial insider ownership filed (Form 3)
• 2026-07-08 — Current report (8-K) filed
• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-06-29 — Proxy statement (DEF 14A) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AURA BIOSCIENCES INC has 126 institutional holders and institutional ownership of 79.3%.

Insider activity

Insiders reported 37 transactions (2 buys, 15 sells) across 10 reporting insiders, with a net reported value of −$612.7K.

Data flags from SEC filings

Related companies

NEUROGENE INC (NGNE) · PRIME MEDICINE INC (PRME) · MONOPAR THERAPEUTICS INC (MNPR) · TENAX THERAPEUTICS INC (TENX) · ENANTA PHARMACEUTICALS INC (ENTA) · PERSPECTIVE THERAPEUTICS INC (CATX)